Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032

Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A698
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Japan Generic Drug Market - Introduction

    4.1    What are Generic Drugs?
    4.2    Unbranded and Branded Generic Drugs
    4.3    Authorized Generic Drugs
5   Why is the Japanese Generic Drug Market So Lucrative
    5.1    Blockbuster Drugs Going Off-Patent
    5.2    Rising Healthcare Costs Coupled with an Increasing Ageing Population
    5.3    Japan Has One of the Lowest Penetration of Generics
    5.4    Incentives for Dispensing Generics
    5.5    Significant Savings for Payers and Providers
    5.6    Biosimilars
6   Global Generic Drug Market
    6.1    Market Performance
        6.1.1 Value Trends
        6.1.2 Volume Trends 
    6.2    Market Breakup by Country
        6.2.1 Market Breakup by Volume
        6.2.2 Market Breakup by Value
    6.3    Market Forecast
    6.4    Most Prescribed Generic and Branded Drugs
7   Japan Generic Drug Market
    7.1    Japan Pharmaceutical Market Performance
        7.1.1 Value Trends
        7.1.2 Volume Trends
        7.1.3 Market Breakup by Type
        7.1.4 Market Forecast
    7.2    Japan Generic Drug Market Performance
        7.2.1 Value Trends
        7.2.2 Volume Trends
        7.2.3 Impact of COVID-19
        7.2.4 Market Forecast
8   SWOT Analysis
    8.1    Overview
    8.2    Strength
    8.3    Weakness
    8.4    Opportunities
    8.5    Threats 
9   Pricing Mechanism and Profit Margins at Various Levels of Supply Chain
10  Porter’s Five Forces Analysis

    10.1    Overview
    10.2    Bargaining Power of Buyers
    10.3    Bargaining Power of Suppliers
    10.4    Degree of Competition
    10.5    Threat of New Entrants
    10.6    Threat of Substitutes
11  Japan Generic Drug Market- Competitive Landscape
    11.1    Japan Generic Drug Market - Competitive Structure
    11.2    Japan Generic Drug Market - Breakup by Key Players
    11.3    Japan Generic Drug Market - Breakup by Distribution Channel
12  Japan Generic Drug Market- Value Chain Analysis
    12.1    Research and Development
    12.2    Manufacturing
    12.3    Marketing
    12.4    Distribution
13  Regulations in Japan Generics Industry
    13.1    Approval Pathway of a Generic Drug in Japan
        13.1.1 Master File Scheme for Active Ingredients
        13.1.2 Equivalency Review
        13.1.3 Conformity Audit
    13.2    Certifications
        13.2.1 MAH (Market Authorization Holder) License for Product Approval
        13.2.2 FMA (Foreign Manufacturer Accredited) Certification for Product Approval
        13.2.3 DMF (Drug Master File) Registration
        13.2.4 GMP (Good Manufacturing Practices) Certification
        13.2.5 Manufacturer’s License
14  Japan Generic Drug Market: Key Success Factors
15  Japan Generic Drug Market: Road Blocks

16  Requirements for Setting up a Generic Drug Manufacturing Plant
    16.1    Manufacturing Process
    16.2    Raw Material Requirements
    16.3    Raw Material Pictures
    16.4    Land and Construction Requirements
    16.5    Machinery and Infrastructure Requirements 
    16.6    Machinery Pictures
    16.7    Plant Layout 
    16.8    Packaging Requirements 
    16.9    Utility Requirements
    16.10    Manpower Requirements
17  Japan Generic Drug Market - Key Company Profiles

List of Figures

Figure 1: Structure of the Pharmaceutical Industry
Figure 2: Classification of Generic Drugs
Figure 3: Penetration of Generic Drugs Across Various Developed Markets
Figure 4: Global: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 5: Global: Generic Drug Market: Sales Volume (in Billion Units), 2018-2023
Figure 6: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2023
Figure 7: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2023
Figure 8: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: Global: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2024-2032
Figure 10: Japan: Pharmaceutical Market: Sales Value (in Billion JPY), 2018-2023
Figure 11: Japan: Pharmaceutical Market: Sales Volume (in Billion Units), 2018-2023
Figure 12: Japan: Pharmaceutical Market Forecast: Sales Value (in Billion JPY), 2024-2032
Figure 13: Japan: Pharmaceutical Market Forecast: Sales Volume (in Billion Units), 2024-2032
Figure 14: Japan: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2018 and 2023
Figure 15: Japan: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2018 and 2023
Figure 16: Japan: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 17: Japan: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 18: Japan: Generic Drug Market: Sales Volume (in Billion Units), 2018-2023
Figure 19: Japan: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2024-2032
Figure 20: Japan: Generic Drug Market: Breakup by Key Players (in %)
Figure 21: Japan: Generic Drug Market: Breakup by Distribution Channel (in %)
Figure 22: Japan: Generic Drug Industry: SWOT Analysis
Figure 23: Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain 
Figure 24: Japan: Generic Drug Industry: Porter’s Five Forces Analysis 
Figure 25: Japan: Generic Drug Industry: Value Chain Analysis
Figure 26: Japan: Generic Drug Manufacturing: Detailed Process Flow
Figure 27: Japan: Generic Drug Manufacturing: Raw Material Requirements
Figure 28: Japan: Generic Drug Manufacturing Plant: Proposed Plant Layout
Figure 29: Japan: Generic Drug Manufacturing: Packaging Requirements
Figure 30: Japan: Approval Pathway for a Generic Drug

List of Tables

Table 1: Japan: Sales (in Billion US$) and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 2: Japan: History of Major Policies to Encourage the Use of Generic Drugs
Table 3: Japan: Expenses of Generic and Branded Drug Manufacturers (in %)
Table 4: Major Biosimilar Product Under Development as of March 2023
Table 5: Japan: Generic Drug Market: Key Industry Highlights, 2023 and 2032
Table 6: Global: Generics Market: Volume Performance of Top Molecules (in Million Prescriptions)
Table 7: Global: Branded Drug market: Volume Performance of Top Branded Drugs (in Million Prescriptions)
Table 8: Japan: Generic Drug Industry: Market Structure
Table 9: Generic Drug Manufacturing Plant: Machinery Costs (in US$)
Table 10: Generic Oncology Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 11: Japan: Data Requirements for a New Generic Drug Application
Table 12: Japan: Various Bioequivalence Guidelines for Generic Drugs
Table 13: Japan: Timeline for New Generic Drug Approval
Table 14: Japan: Review Time of the Application for Partial Change Approval
Table 15: Nichi-Iko Pharmaceutical Co., Ltd: Key Financials (in US$ Million)
Table 16: Sawai Pharmaceutical Co., Ltd: Key Financials (in US$ Million)
Table 17: Towa Pharmaceutical: Key Financials (in US$ Million)
Table 18: Teva Pharmaceutical Ltd: Key Financials (in US$ Million)
Table 19: Fuji Pharma Co Ltd: Key Financials (in US$ Million)

Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More